Features Screener Stocks Charts
Sign In Sign Up

Natco Pharma Limited Income Statement

NSE:NATCOPHARM | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year NATCOPHARM income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 41.27B 47.84B
Cost of Revenue -7.17B -6.90B
Gross Profit 34.10B 40.94B
Sales, General & Admin -15.31B -15.44B
Operating Income 16.93B 23.15B
Profit Before Tax 16.74B 22.91B
Net Income 13.88B 18.83B
Diluted Shares 179.50M 179.11M
Diluted EPS 77.34 105.26

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025